News

Consulting firm outlines timeline for new water source exploration in Blacks Harbour
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
The Malaysian Reserve2d
Cascadia Minerals and Granite Creek Copper Announce Merger to Create a Leading Yukon Copper-Gold Exploration and Development Company
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ Concurrent Non-brokered Private ...
Scientific Research Publishing5d
Case Analysis and Management Strategies of Glucocorticoid-Induced Metabolic Syndrome during Pregnancy ()
Tang, L. , Yang, W. and Wang, Q. (2025) Case Analysis and Management Strategies of Glucocorticoid-Induced Metabolic Syndrome during Pregnancy. Journal of Biosciences and Medicines, 13, 39-45. doi: ...
Junior Mining Network7d
Leocor Mining Begins Summer Exploration Program at the Baie Verte Copper-Gold Project, Newfoundland
TheNewswire - June 04, 2025 - Leocor Mining Inc. (the “Company” or “Leocor”) (CSE: LECR, OTCQB: LECRF; Frankfurt: ...
Disaster deep below: How Calgary's catastrophic feeder main failure was decades in making
What missed opportunities led up to the Bearspaw south feeder main rupture? Water experts and a trove of city documents ...
Le Lézard8d
Personalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced the presentation of new results from the CALLA phase 3 study showing for the first time its ultrasensitive NeXT ...
Iosco County News-Herald8d
Project progress updates, future forecasts shared at RAB meeting
The following is the first of a multi-part story on the Wurtsmith Restoration Advisory Board (RAB) meeting, which was held in ...
TMCnet8d
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...
PipelineReview.com8d
KAHR Bio Announces Positive Phase 2 Results of DSP107 in Combination with anti-PD-L1 in Colorectal Cancer
Abstract Title: Phase 2 dose expansion study of DSP107, a first-in-class bi-specific 4-1BB T-cell engager, with and without atezolizumab in metastatic MSS colorectal cancer patients.
Le Lézard9d
New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced the presentation of new clinical results from the PREDICT DNA and SCANDARE studies highlighting the capabilities of ...